Stratos Wealth Partners, Ltd. Adverum Biotechnologies, Inc. Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$2.87 - $5.92 $430 - $888	-150 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$4.5 - $7.6 $675 - $1,140	150 New	150 $1,000
Q2 2018 Aug 13, 2018	SELL	$5.3 - $6.9 $795 - $1,035	-150 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$3.65 - $7.95 $547 - $1,192	150 New	150 $1,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.